These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17941109)

  • 1. Reversal of trichotillomania with aripiprazole.
    Jefferys D; Burrows G
    Depress Anxiety; 2008; 25(6):E37-40. PubMed ID: 17941109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of restless legs syndrome and trichotillomania with aripiprazole.
    Virit O; Selek S; Savas HA; Kokaçya H
    J Clin Pharm Ther; 2009 Dec; 34(6):723-5. PubMed ID: 20175807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 6. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
    Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
    J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central sleep apnea in a geriatric patient treated with aripiprazole.
    Kohen I; Sarcevic A
    Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
    Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.
    Wolf J; Fiedler U
    J Clin Pharm Ther; 2007 Apr; 32(2):197-8. PubMed ID: 17381670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label trial of aripiprazole in the treatment of trichotillomania.
    White MP; Koran LM
    J Clin Psychopharmacol; 2011 Aug; 31(4):503-6. PubMed ID: 21694623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of low-dose aripiprazole treatment for trichotillomania.
    Yasui-Furukori N; Kaneko S
    Clin Neuropharmacol; 2011; 34(6):258-9. PubMed ID: 22104636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
    Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole-induced seizure.
    Malik AR; Ravasia S
    Can J Psychiatry; 2005 Mar; 50(3):186. PubMed ID: 15830832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.